Vertex Pharmaceuticals Inc./ US92532F1003 /
17/05/2024 11:29:32 | Diferencia +3.3000 | Volumen | Bid15:03:24 | Ask15:03:24 | Capitalización de mecado | Dividendo A. | P/E Ratio |
---|---|---|---|---|---|---|---|
405.6500EUR | +0.82% | 55 Volumen de negocios: 22,320.7500 |
407.5000Volumen de oferta: 30 | 409.6500Tamaño/ Volumen/ Formato de Ask: 30 | 104.64 mil millonesEUR | - | - |
GlobeNewswire
15:00
STEALTHGAS INC. Announces the Date for the Release of the First Quarter 2024 Financial and Operating...
GlobeNewswire
15:00
Expense Management Provider Announces Cash Advance Feature to Simplify Small Expense Claims
GlobeNewswire
15:00
EuroDry Ltd. Sets Date for the Release of First Quarter 2024 Results, Conference Call and Webcast
GlobeNewswire
15:00
Connexa Shareholders Approve Transaction to Acquire Hong Kong Based Yuanyu Enterprise Management
GlobeNewswire
15:00
Good Company Launches $30 Million Fund to Drive Innovation in Mission-Driven Startups Addressing Glo...
GlobeNewswire
15:00
Recor Medical Champions Global Action on World Hypertension Day: Early Intervention and Continued I...
GlobeNewswire
15:00
Acme United Corporation to Present at the Singular Research Spring Select Webinar on May 22, 2024
GlobeNewswire
15:00
Fitness Club Management and Fitness Industry Veteran Al Noshirvani Transform AARP Health Club to Met...
GlobeNewswire
14:50
io.finnet Launches Its Cutting-Edge Digital Asset Custody Solution for institutions: io.vault
GlobeNewswire
14:45
NeoVolta CEO Ardes Johnson Gives Expert Testimony to the US International Trade Commission Advising ...
GlobeNewswire
14:35
Appia Rare Earths and Uranium Corp. to Present at the Clean Energy & Precious Metals Hybrid Investor...
- Primera página
- Atrás
- 1
- 2
- 3
- 4
- Siguiente
- Última página